Tiffany Lu, MD, MS, FASAM
President
Associate Medical Director of Addiction Services, New York City Health + Hospitals | Jacobi
Tiffany Lu, MD, MS, FASAM is Associate Medical Director of Addiction Services at New York City Health & Hospitals/Jacobi, where she oversees the safety net hospital’s addiction consult service and outpatient addiction clinic, with an integrated opioid treatment program underway. She is also Associate Professor of Medicine and Psychiatry at the Albert Einstein College of Medicine, where she leads addiction related education for medical students, residents, and fellows. Dr Lu is currently Education Chair and President-Elect for the New York Chapter of ASAM and member of the ASAM Quality Improvement Council.
Prior to joining Jacobi, Dr Lu was the Medical Director of Montefiore Medical Center’s Buprenorphine Treatment Network, where she led the implementation of office-based addiction treatment across 7 community health centers and expanded clinical training for medical trainees in addiction medicine.
Dr. Lu graduated from UCSF School of Medicine and completed her Internal Medicine Primary Care Residency at Massachusetts General Hospital. She holds a Masters of Science in Clinical Research Methods from Albert Einstein College of Medicine.
Aaron D. Fox, MD, MS, DFASAM
Immediate Past President
Nominations/Membership Committee Chair
Professor of Medicine
Albert Einstein College of Medicine/Montefiore Medical Center
Dr. Aaron Fox is board certified in internal medicine and addiction medicine. His clinical care and research involves opioid use disorder treatment in primary care, syringe services programs, and criminal justice settings. Dr. Fox is the Director of the Bronx Transitions Clinic, which provides a medical home to people who were recently released from jail or prison, and he maintains an NIH-funded program of clinical research focused on buprenorphine treatment interventions
Linda Wang, MD
President-Elect
Addiction Medicine Physician, REACH Program at Mount Sinai
Linda Wang, MD is an addiction medicine physician at the REACH Program at Mount Sinai, a comprehensive primary care program for people who use drugs. At REACH, she leads a nurse care manager program providing longitudinal care for people who use drugs, which has expanded access to buprenorphine treatment across Mount Sinai Hospital. She is the Medical Director for the VOCAL-NY + Mount Sinai Cures Clinic, which provides low-threshold medical services such as hepatitis C treatment, buprenorphine, and wound care for people who use drugs that is co-located within VOCAL-NY’s syringe service program. In her role as Medical Director for the Hepatitis C and Drug User Health Center of Excellence at Mount Sinai, she develops and coordinates state-wide training and conferences for NYS clinician to strengthen clinical practice and improve patient outcomes. At Mount Sinai Health System, she leads several efforts to improve addiction care across the care continuum, including advocacy for stigma-free care for people who use drugs. She is Chair of the NYS Drug User Health Working Group. She was formerly the NYSAM Education Committee Chair.
She is Associate Professor of Medicine & Medical Education at the Icahn School of Medicine. She received her medical degree from the Icahn School of Medicine at Mount Sinai and completed residency in the Primary Care and Social Internal Medicine Program at Montefiore Medical Center.
Judith Cole, MSN, AGPCNP-BC, WHNP-BC, CARN-AP
Nurse Practitioner and Senior Director of Medical Services, Harlem
United Integrated Harm Reduction Department, New York City
Judith Cole, MSN, AGPCNP-BC, WHNP-BC, CARN-AP is a dual-certified
Nurse Practitioner and Senior Director of Medical Services within Harlem
United’s Integrated Harm Reduction Department in New York City. She
launched and leads Harlem United’s street-based medical program, delivering low-threshold care, including buprenorphine and hepatitis C treatment, for PWUD and those experiencing unstable housing. Previously, she practiced primary care in women’s shelters across Manhattan and the Bronx.
In her current role, Judith drives program development and systems change designing policies and clinical protocols, guiding operations, and managing contract-funded resources while collaborating with external research partners to evaluate program effectiveness. Judith is a prescribing provider with Ophelia Health and provides technical assistance through the Opioid Response Network. She serves on NYSAM’s Education and Membership Committees, co-chaired NYSAM’s 2025 and 2026 annual conferences, and delivers community-based trainings on harm reduction and trauma informed care.
Zina Huxley-Reicher, MD
Secretary
Addiction medicine fellow at Montefiore Medical Center
Zina Huxley-Reicher is currently an addiction medicine fellow at Montefiore Medical Center after completing her Internal Medicine and Primary Care residency at Yale New Haven Health.
Prior to medical school the Icahn School of Medicine at Mt. Sinai, she worked for the New York City Department of Health and Mental Hygiene on overdose prevention and naloxone distribution projects which was her introduction to caring for folks who use substances. Over the years her work has focused
on providing care to those who use substances in a large variety of settings as well as the care of those returning home from jail and prison. She is passionate about improving access to
substance use care, improving policies at all levels to allow our systems to better care for those individuals and partnering with communities to include and empower patients in their own care.
Zoe Adams, MD, MA
Communications Chair
Addiction Medicine Fellow, NYU/NYC Health + Hospitals
Zoe Adams, MD, MA is an addiction medicine fellow at NYU Langone Health. She completed her residency in internal medicine at Massachusetts General Hospital/Harvard Medical School in 2025 and received her MD from Yale School of Medicine in 2022. While in medical school, she obtained an MA from Yale in the History of Science and Medicine, where she focused on the history of methadone treatment in the U.S. Her writing on addiction has been published in The Washington Post, Slate, and The Nation, among other outlets.
Tricia Bautista, MD, FASAM
At Large Member
Medical Director of Substance Use Services for NYC Health &
Hospitals/Correctional Health Services
Tricia Bautista, MD, FASAM is a
family medicine physician and addiction medicine specialist
dedicated to serving populations at the complex intersection of
healthcare and the justice system. Currently, she serves as the
Medical Director of Substance Use Services for NYC Health &
Hospitals/Correctional Health Services, primarily caring for
incarcerated individuals at Rikers Island and providing
transitional primary care upon re-entry to community services at
Kings County Hospital.
She is increasingly focused on the medical-legal intersection,
exploring how clinical expertise can inform and improve
problem-solving courts. And she is passionate about
empowering medical trainees and healthcare professionals
through enhanced addiction care education, believing that a
well-informed workforce is the foundation of systemic change.
As a Montefiore/Albert Einstein addiction medicine fellowship
alum, she is pursuing an MPH at Johns Hopkins Bloomberg
School of Public Health to further her impact on justice-involved
populations.
Mashal Khan, MD
At Large Member
Assistant Professor of Clinical Psychiatry, Weill Cornell Medicine
Mashal Khan, M.D., is an Assistant Professor of Clinical Psychiatry at Weill Cornell Medicine and an addiction psychiatrist embedded within the Liver Transplant Program. In this role, he evaluates transplant candidates and living donors and provides integrated psychiatric care to support patients
through the transplant process. His clinical work focuses on improving outcomes for individuals with alcohol-associated liver disease through evidence-based addiction treatment and
multidisciplinary care.
Dr. Khan graduated from Xi’an Jiaotong University School of Medicine and completed his psychiatry residency at Maimonides Medical Center, where he served as Chief Resident. He went on
to complete a fellowship in Addiction Psychiatry at the Icahn School of Medicine at Mount Sinai (Mount Sinai St. Luke’s–West). He is board-certified in both General Psychiatry and Addiction Psychiatry by the American Board of Psychiatry and Neurology.
At Weill Cornell Medicine, Dr. Khan serves as Associate Program Director of the Addiction Psychiatry Fellowship and Director of the Center for Alcohol and Liver Medicine. He is an active member of the NYSAM Board, and is committed to advancing evidence-based addiction treatment, reducing stigma, and strengthening collaboration across disciplines to improve care for individuals with substance use disorders
Dr. Khan’s academic work focuses on advancing care for substance use disorders through technology-assisted
interventions and integrated medical-psychiatric treatment models. He is the author of Technology-Assisted Interventions for Substance Use Disorders and From Stigma to Support: A New Vision for Alcohol Use Disorder Treatment and Recovery, and has
contributed to multiple book chapters and peer-reviewed publications.
Theresa Baxter, CARN-AP
Associate Member
Family Nurse Practitioner
Theresa Baxter is a Family Nurse Practitioner with experience in pain and
substance use disorder management, acute and chronic. She started in 2005 as an RN on the Surgical ICU at Upstate, went on to complete a Master of Science in Nursing from SUNY Upstate College of Nursing in 2013, began working with the Department of Anesthesia on the Acute Pain Service. Realizing the gap in care for patients with Opioid Use Disorder she continued her training and went on to help create the Addiction Consult team, primarily specializing in medical management of alcohol and opioid use disorder, pain management. She is a board-Certified Addiction Registered Nurse- Advanced Practice: (CARN-AP).
Theresa remains committed to professional development and patient
advocacy, regularly participating in continuing education, contributions to
initiatives aimed at improving addiction management practices across healthcare settings. Providing evidence based and often “outside of the box” Substance Use Disorders treatment and empowering others to do the
same has been a driving force for Theresa, as well as advocating for
compassionate care, stigma and harm reduction.
Zakary Walizadeh, PA-C
Associate Member
Clinical Manager at Ophelia Health
Zakary Walizadeh, PA-C, is a physician assistant specializing in addiction
medicine. He serves as a Clinical Manager at Ophelia Health, a telehealth
opioid use disorder treatment provider, where he practices clinically while
leading a team of clinicians caring for patients nationwide. He is deeply
committed to harm reduction, expanding access to low-barrier addiction treatment, and championing compassionate, stigma-free care for people who use drugs.
Marco Barber Grossi, MD
Advocacy, Legislative & Public Policy Committee Chair
Attending Physician, Departments of Medicine and Behavioral Health, NYC Health + Hospitals/Jacobi
Marco Barber Grossi is currently an attending physician for the Departments of Medicine and Behavioral Health at NYC Health + Hospitals/Jacobi.
Briesny Tejada, MD
Medical Student/Resident/Fellow Member
Addiction Medicine Fellow at NYU
Dr. Briesny Tejada is an Addiction Medicine Fellow at NYU. She
completed her residency in Family Medicine at Montefiore Medical Center, where she participated as a mentee in the New York State Office of Addiction Services and Supports (OASAS)
Addiction Medicine Mentored Training Program. During this time, she designed and led a resident-focused quality
improvement initiative to improve screening for unhealthy alcohol use in the primary care setting. At NYU, Dr. Tejada currently serves as a mentor to scholars in the Multidisciplinary Addiction Training Scholarship Program. Her clinical and academic interests include reducing stigma in addiction care and expanding access to evidence-based treatment in community-based settings. Dr. Tejada is committed to providing compassionate addiction
treatment and comprehensive primary care to patients in underserved urban communities. She hopes to contribute to efforts that improve education, mentorship, and systems of care
for individuals affected by substance use disorders. As a board member, she would be eager to support initiatives that strengthen mentorship, advance addiction medicine education, and expand access to evidence-based care for underserved communities.
Philip J. McFarland, MD
Medical Student/Resident/Fellow Member
PGY4 psychiatry resident at Montefiore Medical Center
Philip J. McFarland, MD, is a PGY4 psychiatry resident at Montefiore Medical Center, where he serves as Administrative Chief Resident and is the founding member of the Community
Psychiatry Concentration with a focus on addiction medicine. He earned his MD from Tufts University School of Medicine after completing a BS in Molecular Biology at Marquette University.
Dr. McFarland is a participant in the OASAS-funded Addiction Medicine Mentorship Program and leads a multidisciplinary steering committee developing harm-reduction services for
patients with substance use disorders at Montefiore Behavioral Health Center. He will begin an Addiction Psychiatry Fellowship at NYU Grossman School of Medicine in July 2026. His clinical
and academic interests center on expanding community-based addiction treatment and integrating harm reduction approaches within public mental health systems.
Position Descriptions
The President shall be the Chief Executive Officer of NYSAM and serve as Chairperson of the BOD. The President shall serve ex-officio as a member of all committees, shall preside at meetings of NYSAM and the ASAM Chapters Council. The President’s duties also include facilitating the BOD meetings, developing the agenda for the BOD meetings, liaising with the BOD committees, appointing the committee Chairs, engaging with other entities, appointing ad hoc committees, and engaging with ASAM and other public entities. The President shall perform such duties as may be prescribed by the Bylaws and the BOD. The President may appoint another BOD member to liaise with outside entities as needed.
The President-Elect, in the absence or disability of the President, shall exercise the powers of the President. The President-Elect shall perform such other duties as may be assigned by the President or BOD. The President-Elect assists with the President in implementing strategic planning for the BOD and assists in liaising with the committees.
The Immediate Past-President shall undertake and perform duties as may be assigned by the President, advises the President on BOD precedent and the relationship with ASAM, and shall be Chair of the Nominations/Membership Committee.
In the circumstance that the Immediate Past President cannot fulfill their role, the role of Chair of the Nominations/Membership Committee shall be appointed for the duration of the term by the President with approval of 50% or more of the BOD. The individual appointed should be an individual already on the BOD.
The duties of Secretary shall include the following in conjunction with the Executive Director: arrange, schedule, and send notice of BOD meetings, keep an accurate record of the proceedings of the meetings of NYSAM and the NYSAM BOD; preserve records, documents, and correspondence; cause notice to be given of elections, meetings of NYSAM, and meetings of the BOD; and perform all other duties incident to the office of Secretary or oversee staff in the exercise thereof.
The Secretary also shall ensure that a complete list of the members entitled to vote at the annual meeting, with the address of record for each member is prepared and accurate. This list should be available at all NYSAM meetings and should be filed in the administrative support’s corporate office or cloud-based electronic storage system.
In the circumstance that the Secretary cannot fulfill their role, the office of Secretary shall be appointed for the duration of the term by the President with approval of 50% or more of the BOD. The individual appointed should be an individual already on the BOD.
The Treasurer shall be the custodian of NYSAM’s funds. The treasurer will work with the NYSAM accountant to oversee that NYSAM follows all federal tax filing requirements. The Treasurer or individual designated by the BOD, in conjunction with the NYSAM accountant or NYSAM administrative support staff, shall deposit these funds in the NYSAM name in such depositories as the Finance Committee following the guidelines of the Bylaws and BOD, shall recommend. The Treasurer, or individual designated by the BOD, shall dispense funds as authorized by the BOD. The Treasurer shall report an accurate account of the financial standing of NYSAM at the annual meeting of NYSAM, and at least quarterly at BOD meetings. The Treasurer shall provide to the BOD an annual financial statement, at the request of the BOD. The Treasurer shall Chair the Finance Committee.
In the circumstance that the Treasurer cannot fulfill their role, the office of Treasurer shall be appointed for the duration of the term by the President with approval of 50% or more of the BOD. The individual appointed should be an individual already on the BOD.
The members-at-large of the BOD are elected by the NYSAM general membership based on a slate proposed by the Nominations/Membership Committee. The member-at- large term is 2 years. Members-at-Large may be assigned duties and responsibilities by the President.
The associate members (2) of the BOD are elected by the NYSAM general membership based on a slate proposed by the Nominations/Membership Committee. The associate member term is 2 years. Members may be assigned duties and responsibilities by the President.
The early career member of the BOD is elected by the NYSAM general membership based on a slate proposed by the Nominations/Membership Committee. The Early Career member is a physician in their first two years after completing an accredited residency or fellowship program or in their first two years of practicing Addiction Medicine as a significant portion of their practice. The early career member term is 2 years. Early career members may be assigned duties and responsibilities by the President.
The medical student/resident/fellow members of the BOD are elected by the NYSAM general membership based on a slate proposed by the Nominations/Membership Committee. Given the demands of trainees’ schedules, there will be a member and an alternate member elected to the BOD. Both members may attend monthly BOD meetings; however, there will be one vote only for BOD decisions. The member will have that vote and if the member is not present at a BOD meeting, then the alternate member will have voting power. Each member’s term is 2 years. Members may be assigned duties and responsibilities by the President.